BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress

  October 23, 2024

   · 

  6 min read
• Press Releases

  Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024

  October 23, 2024

   · 

  4 min read
• Press Releases

  Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

  October 23, 2024

   · 

  9 min read
• Press Releases

  Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations

  October 23, 2024

   · 

  9 min read
• Press Releases

  Quoin Pharmaceuticals Announces Further International Expansion of Ongoing Clinical Trials for Netherton Syndrome

  October 23, 2024

   · 

  4 min read
• Press Releases

  Orna Therapeutics Unveils Novel In Vivo Gene Editing Data Highlighting Engineering and Delivery Approach at the 31st Annual European Society of Gene & Cell Therapy Congress

  October 23, 2024

   · 

  3 min read
• Press Releases

  SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

  October 23, 2024

   · 

  7 min read
• Press Releases

  NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation

  October 23, 2024

   · 

  3 min read
• Press Releases

  Ellison Institute of Technology Los Angeles Accelerates Cancer Research with Sapio LIMS

  October 23, 2024

   · 

  3 min read
• Press Releases

  AscellaHealth Releases Q3 2024 Specialty & Rare Pipeline Digest™: FDA-Approved Biosimilars Outpaces Cell and Gene Therapy Amid Complex Regulatory Challenges

  October 23, 2024

   · 

  3 min read